Hot AXIOS™ for Bile Duct Drainage in Malignant Stenosis
← catalyst calendarNCT06750146 · readout ≤ 285 d
Sponsored by Boston Scientific Corporation (industry) · BSX — their whole pipeline →.
Phase
Not applicable
Status
Suspended
Study type
Interventional
Design
Na · None · Treatment
Enrollment
162estimated
Sites
18
Country
France
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Why the sponsor stopped it
Sponsor decision
As filed on the registry record, in the sponsor's own words.
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-06-19 | actual | When the study began enrolling |
| Primary completion | May 2027 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | May 2027 | estimated | The whole study's end, after follow-up |
| First posted | 2024-12-27 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-08-11 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Malignant Biliary Stenosis
Intervention
- Device: Hot AXIOS™ Stent and Electrocautery Enhanced Delivery System — also filed as Hot AXIOS™
Primary outcome
what the primary-completion date above is the date OFQuality of Life Measurement - Jaundice Dimension
measured 2 months (± 15 days)
Permalink · BSX's whole pipeline · Catalyst calendar · Every registered study · What changed